Insights into Intrinsic Atopic Dermatitis: immunogenicity, Dysbiosis, and Imaging (Reflectance Confocal Microscopy, Optical Coherence Tomography)
DOI: https://doi.org/10.2147/ccid.s459096
2024-06-12
Clinical Cosmetic and Investigational Dermatology
Abstract:Elena Gavrilita, 1, 2 Simona Ioana Silion, 1, 2 Miruna Lorelei Bitca, 1 Alin Laurentiu Tatu 1– 3 1 Dermatology Department, "Sf. Cuvioasa Parascheva" Clinical Hospital of Infectious Diseases, Galați, Romania; 2 Multidisciplinary Integrated Center of Dermatological Interface Research MIC-DIR, "Dun&abreverea de Jos" University, Galați, Romania; 3 Clinical Medical Department, Faculty of Medicine and Pharmacy, "Dun&abreverea de Jos" University, Galați, Romania Correspondence: Elena Gavrilita, Tel +40746680485, Email Atopic dermatitis (AD) is a frequent inflammatory condition that usually begins during early childhood, but it increasingly starts to debut, even in the elderly. Based on immunoglobulin E (IgE) levels and clinical features, two subsets of this disease have been recognized: intrinsic and extrinsic. When speaking about AD, most specialists think about filaggrin (FLG) mutations resulting in epidermal barrier defects, which is the case in most atopic patients, but some have a normal barrier, as seen by imaging, and still have specific clinical lesions along with metal allergies. Specific molecules (IL-10, IFN-γ, and HBD-3) have been shown to greatly impact the interactions between internal and external factors in this peculiar form of AD. A less-known protein, suprabasin, has been highlighted as a promising explanation for nickel anomalies in intrinsic AD. Keywords: atopy, OCT, RCM, HBD-3, IFN-γ, suprabasin Atopic dermatitis (AD) is a well-known chronic inflammatory skin condition associated with pruritus, usually beginning during the first years of childhood; however, it can also affect the elderly. Chronic hand eczema can be a primary sign in adults. 1 Two types of AD have been identified, an extrinsic type (eAD), which is mainly characterized by increased levels of immunoglobulin E (IgE) and affects the majority of patients (70–80%), and an intrinsic (iAD) form, which has normal IgE levels but still has positive results for the air-borne and food allergens tests, delayed onset, and has been observed more often in females. 1 For the latest type, intrinsic AD, some authors have proposed terms such as "non-allergic AD" or 'atopiform dermatitis', 2 which mimicked the pattern of classical AD. 2 These patients have a less frequent personal or family history of atopy and very low rates of recurrent conjunctivitis. 2 Tokura et al have described that the main features of intrinsic AD would include a later onset, milder forms, the presence of Dennie-Morgan folds, lack of ichthyosis vulgaris, and palmar hyperlinearity. 3 Brenninkmeijer added less frequently observed keratosis pilaris, pityriasis alba, and nonspecific hand or foot eczema. 2 At the molecular level, filaggrin gene mutations are less important in iAD, as they appear mostly in eAD, where they cause an increased percutaneous transfer of external antigens through the disrupted barrier. 4 Immunologically, iAD has low levels of interleukin (IL) −4, −5 and −13, but high expression of interferon-gamma (IFN-γ+) Th1 cells. 3,5,6 Keratinocytes, which are influenced by IL-4 and IL-13, exhibit reduced filaggrin (FLG) gene expression 7 , loricrin and involucrin downregulation, all leading to the compromised barrier seen in eAD. In a Japanese study published in 2012, the team observed an increase in IFN-γ+ Th1 cells along with low levels of IgE, stimulating naive B cells to produce IgE and discovered that even a small amount of IFN could inhibit IgE production, leading to the conclusion that IFN-γ contributes to the normal level of IgE in IgE-low AD (iAD). 6,8 Another key action of IFN-γ is the upregulation of Th1 chemokine production and the downregulation of Th2 (IL-4 and IL-13). In eAD, where there is already a barrier defect, Th2 cells and eosinophils infiltrate the lesions; however, in iAD, higher levels of IFN-γ inhibit the chemotaxis and action of Th2 chemokines. 9 In contrast, TNF-α/IFN-γ induces inflammatory cytokines such as IL-1β, IL-8, and IL-6. IFN-γ causes abnormal lipid composition in AD skin, leading to a defectuos barrier. 10 It has been previously shown that IL-4 and IL-13 (Th2 cytokines) downregulate antimicrobial peptides (AMPs) expression and inhibit epidermal differentiation. 5,11 In 2005, Howell et al compared the levels of LL-37 in normal, eAD, iAD, and allergic contact dermatitis (ACD) tissue samples by immunostaining. The results showed that there was significantly lower LL-37 staining, especially in the granular cell layer and stratum corneum in the normal and AD skin, compared to ACD. 12 Past studies showed that cathelicidin LL-37 and HBD-2 have a low expression in non inflamed skin o -Abstract Truncated-
dermatology